|
|
|
Insider
Information: |
Hsiao Jane Ph D |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
50,158,203 |
|
Indirect Shares
|
33,836,183 |
|
|
Direct
Value |
$48,627,270 |
|
|
Indirect Value
|
$17,247,610 |
|
|
Total
Shares |
83,994,386 |
|
|
Total
Value |
$65,874,880 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-64.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Asensus Surgical Inc |
ASXC |
Director |
2021-07-01 |
336,895 |
2021-07-01 |
96,746 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director |
2007-01-31 |
1,134,060 |
|
0 |
Premium* |
|
Opko Health Inc |
OPK |
|
2024-07-24 |
28,499,880 |
2024-07-24 |
5,127,404 |
Premium* |
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
2013-08-29 |
0 |
Premium* |
|
Non Invasive Monitoring Systems ... |
NIMU |
Interim CEO, Director,... |
2018-12-21 |
16,752,074 |
2018-12-21 |
20,883,660 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
Director |
|
0 |
2010-01-25 |
2,231,719 |
Premium* |
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
3,435,294 |
2016-03-15 |
5,496,654 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ASXC |
Asensus Surgical Inc |
Director |
|
2005-04-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200,000 |
|
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2007-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
215,000 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2007-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,588,965 |
2,803,965 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2008-05-28 |
4 |
B |
$2.15 |
$129,000 |
I/I |
60,000 |
60,000 |
2.25 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
1,360,000 |
2.25 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-09-10 |
4 |
A |
$0.00 |
$0 |
I/I |
76,261 |
1,913,470 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-09-10 |
4 |
OE |
$1.00 |
$477,209 |
I/I |
477,209 |
1,837,209 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2012-02-17 |
4 |
B |
$0.40 |
$1,800,000 |
D/D |
4,500,000 |
7,303,965 |
3.92 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2013-03-22 |
4 |
B |
$0.25 |
$1,000,000 |
D/D |
4,000,000 |
11,437,681 |
3.92 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2013-12-06 |
4 |
OE |
$0.40 |
$1,750,000 |
I/I |
4,375,000 |
6,288,470 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2013-12-06 |
4 |
OE |
$0.40 |
$1,750,000 |
D/D |
4,375,000 |
15,812,681 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2018-03-22 |
4 |
OE |
$1.65 |
$660,000 |
D/D |
400,000 |
3,562,536 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
20,362 |
3,582,898 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,380 |
3,603,278 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,488 |
307,664 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,231 |
336,895 |
0 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2014-03-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,545,993 |
|
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,496,654 |
5,496,654 |
0 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-03-25 |
4 |
B |
$0.92 |
$2,024,000 |
D/D |
2,200,000 |
2,200,000 |
2.39 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2016-03-15 |
4 |
B |
$0.51 |
$630,000 |
D/D |
1,235,294 |
3,435,294 |
2.39 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Director |
|
2008-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,400,000 |
|
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
|
2013-04-08 |
4/A |
B |
$0.05 |
$100,000 |
D/D |
2,000,000 |
10,400,000 |
3.23 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
|
2013-04-08 |
4 |
B |
$0.05 |
$1,000,000 |
D/D |
20,000,000 |
10,400,000 |
3.23 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEO |
|
2018-12-21 |
4 |
B |
$0.07 |
$1,461,856 |
I/I |
20,883,660 |
20,883,660 |
2.64 |
- |
|
94 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|